Infectious Diseases News and Research

RSS

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team.

From The Native Antigen Company 23 Nov 2022

Recommendations to improve health and wellbeing of individuals incarcerated in U.S. prisons

Adequately funded policies and procedures are needed to reduce health care disparities in access to and the quality of health care for the U.S. jail and prison population says the American College of Physicians (ACP) in a new policy paper published today in the Annals of Internal Medicine.

23 Nov 2022

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Infectious diseases expert George Thompson has been studying and treating fungal diseases for over two decades. He monitors their spread, symptoms and relative risks.

22 Nov 2022

Previously unknown links between genetic factors in ASD identified

In a new study published today in Cell Reports, researchers from the Donald K. Johnson Eye Institute (DKJEI), part of the Krembil Research Institute at University Health Network, have identified previously unknown connections between genetic factors in Autism Spectrum Disorder (ASD).

22 Nov 2022

Monkeypox viruses can be inactivated by two who-recommended hand disinfectants

People in many countries are contracting monkeypox, even though they have not travelled to any regions where the virus is mainly circulating.

22 Nov 2022

Study shows sylvatic origin of chikungunya virus transmission among nonhuman primates of Myanmar

Researchers investigated the potential exposure of peri-urban non-human primates (NHPs) residing near Yangon to arboviruses that have raised health concerns.

22 Nov 2022

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products.

22 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

In a recent study published in the journal Advanced Science, researchers developed molecularly imprinted nanoparticles (nanoMIPs) with broad-spectrum activity against lethal viruses.

21 Nov 2022

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America's healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

21 Nov 2022

NIAID awards more than $12 million for the development of antiviral therapies

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

21 Nov 2022

Johns Hopkins experts receive PCORI funding to optimize antibiotic therapy for gram-negative bloodstream infections

To study how best to treat potentially dangerous infections commonly seen in people with underlying chronic medical conditions, two infectious disease experts at Johns Hopkins Medicine have been awarded $10 million in research funding over five years by the Patient-Centered Outcomes Research Institute.

21 Nov 2022

The Native Antigen Company introduces new range of influenza antigens

From The Native Antigen Company 21 Nov 2022

WHO‒recommended alcohol-based hand rub formulations show efficacy against Monkeypox virus

Researchers demonstrated the efficacy of two World Health Organization (WHO)‒recommended alcohol-based hand rub solutions to inactivate the monkeypox virus (MPXV).

21 Nov 2022

Study suggests bats are an underrecognized arenavirus reservoir

Researchers reported the detection of arenavirus RNA from various species of bats sampled between 2007 and 2011 from Brazil.

21 Nov 2022

In our rapidly changing world, parasites and vectors thrive

Recently, researchers reviewed the incidence and management of emerging parasites and vectors associated with human and veterinary organisms.

20 Nov 2022

Unusual Zika virus-specific antibody exhibits ultrapotent neutralization

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identified by a team led by Weill Cornell Medicine, NewYork-Presbyterian and National Institutes of Health (NIH) investigators.

20 Nov 2022

Researchers identify a novel RSV variant associated with prolonged infection

Researchers examine pathogen or host genetic risk factors for RSV infection, as well as whether certain viral variants are associated with prolonged infection.

20 Nov 2022

Scientists explore bat sarbecovirus isolation in Japan

Researchers performed bat sarbecovirus isolation experiments using Rhinolophus cornutus bats from several regions in Japan that were phylogenetically situated in the same cluster of viruses related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Nov 2022

Bombali ebolavirus has been detected among bats in Mozambique

Researchers reported on the detection of Bombali virus (BOMV, of the ebolavirus genus) ribonucleic acid (RNA) among three free-tailed Mops condylurus (Molossidae) bat species in Mozambique.

18 Nov 2022

Infectious Diseases News and Research

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

Recommendations to improve health and wellbeing of individuals incarcerated in U.S. prisons

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Previously unknown links between genetic factors in ASD identified

Monkeypox viruses can be inactivated by two who-recommended hand disinfectants

Study shows sylvatic origin of chikungunya virus transmission among nonhuman primates of Myanmar

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

Exploring antibiotic resistance in the EU

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

NIAID awards more than $12 million for the development of antiviral therapies

Johns Hopkins experts receive PCORI funding to optimize antibiotic therapy for gram-negative bloodstream infections

The Native Antigen Company introduces new range of influenza antigens

WHO‒recommended alcohol-based hand rub formulations show efficacy against Monkeypox virus

Study suggests bats are an underrecognized arenavirus reservoir

In our rapidly changing world, parasites and vectors thrive

Unusual Zika virus-specific antibody exhibits ultrapotent neutralization

Researchers identify a novel RSV variant associated with prolonged infection

Scientists explore bat sarbecovirus isolation in Japan

Bombali ebolavirus has been detected among bats in Mozambique

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News